Not yet recruitingNCT06323408
Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas
Studying Embryonal tumor with multilayered rosettes
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Regensburg
- Principal Investigator
- Peter Hau, Prof.University Hospital Regensburg
- Intervention
- Tissue, blood, cerebrospinal-spinal fluid(diagnostic_test)
- Enrollment
- 72 enrolled
- Eligibility
- 15-39 years · All sexes
- Timeline
- 2025 – 2026
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06323408 on ClinicalTrials.govOther trials for Embryonal tumor with multilayered rosettes
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06861244Embryonal Tumor With Multilayered RosettesUniversity of California, San Francisco
- RECRUITINGNCT04794686ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer RosettesHackensack Meridian Health
See all trials for Embryonal tumor with multilayered rosettes →